A common cancer drug has been restructured to make its cancer cell killing abilities up to 20,000 times more effective while also reducing its toxicity

far more powerful and targeted—leaving healthy cells unharmed.

The new drug entered leukemia cells 12.5 times more efficiently, killed them up to 20,000 times more effectively and reduced cancer progression 59-fold. This was all without detectable side effects, according to the researchers.

It has only been tested in animals thus far, but wow